Health and Healthcare
Biotech Short Interest (May 2007) (AMGN, GILD, CELG, GENZ, MEDI, BIIB, AMLN, IMCL, DNDN, NFLD)
Published:
Stock Tickers: AMGN, GILD, CELG, GENZ, MEDI, BIIB, AMLN, IMCL, DNDN, NFLD
The short interest is on the rise overall, but the odd thing is that the short interest in biotech shares is really a mixed bag. Some of the short interest indications doesn’t really look like the short sellers were making the right moves, but time will be the true judge. Here are the key NASDAQ biotech short interest numbers:
Stock (Ticker MAY APRIL CHANGE
Amgen (AMGN) 25.59M 27.99M -8.5%
Gilead (GILD) 12.99M 13.57M -4.2%
Celgene (CELG) 25.9M 24.6M 5%
Genzyme (GENZ) 7.05M 6.75M 4.5%
Medimmune (MEDI) 20.5M 17.2M 18.8%
Biogen-Idec (BIIB) 9.61M 9.09M 5.7%
Amylin Pharma (AMLN) 18.7M 20.0M -6.4%
Imclone (IMCL) 6.26M 7.89M -20.6%
Dendreon (DNDN) 41.6M 33.9M 22.9%
Northfield (NFLD) 6.24M 6.62M -5.7%
Jon C. Ogg
May 25, 2007
Robinhood set out to democratize investing to individuals, and it’s not slowing down. The app makes it possible to buy and sell stocks, mutual funds, trade options, and even cryptocurrencies like Bitcoin (BTC) and Ethereum (ETH).
With FDIC insurance ,an award winning design, and benefits like IRAs and more, Robinhood could be your path to a richer tomorrow.
Sign up today — click here to start your journey.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.